[AsCNP_O5] Oral Session 5
Schizophrenia

[AsCNP-O5-5] Clozapine-associated obsessive-compulsive symptoms and their management: a systematic review and analyses of 107 reported cases

^○David D. KIM^{1, 2}, Alasdair M. BARR^{1, 2}, Cynthia LU², S. Evelyn STEWART^{2, 3}, William G. HONER^{2, 3}, Ric M. PROCYSHYN^{2, 3} (1. Department of Anesthesiology, Pharmacology and Therapeutics, University of British Columbia, Vancouver, Canada, 2. British Columbia Mental Health & Substance Use Services, Vancouver, Canada, 3. Department of Psychiatry, University of British Columbia, Vancouver, Canada)